Drugs / 2-hydroxy-4-methoxyacetophenone
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04657926 | Sep 2020 → Sep 2021 | osteoarthritis, knee | AKL Research and Development | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2-hydroxy-4-methoxyacetophenone | “2-hydroxy-4-methoxyacetophenone (2H4MA)” NCT04657926 ↗ |
| Known as | 2H4MA | “2-hydroxy-4-methoxyacetophenone (2H4MA)” NCT04657926 ↗ |